Takahama, Hiroyuki
,
Asakura, Masanori
Abe, Yukio
Ajioka, Masayoshi
Aonuma, Kazutaka
Anzai, Toshihisa
Hayashi, Takaharu
Hiramitsu, Shinya
Kawai, Hiroya
Kioka, Hidetaka
Kimura, Kazuo
Lim, Young-Jae
Matsuoka, Ken
Motoki, Hirohiko
Nagata, Yoji
Nakamura, Sunao
Ohte, Nobuyuki
Ozaki, Yukio
Sasaoka, Taishi
Tamaki, Shunsuke
Hamasaki, Toshimitsu
Kitakaze, Masafumi
Funding for this research was provided by:
Takeda Pharmaceutical Company Limited
Article History
First Online: 5 July 2018
Compliance with Ethical Standards
:
: H.T. reports grants from The Bayer Scholarship for Cardiovascular Research; grants from Japan Ministry of Education, Culture, Sports, Science and Technology; personal fees from Otsuka; personal fees from Ono Pharmaceutical Co.; and personal fees from Daiichi Sankyo. M. K. reports grants and personal fees from Takeda, during the conduct of the study, and grants from Japanese government; grants from Japan Heart Foundation; grants from Japan Cardiovascular Research Foundation; grants and personal fees from Asteras; grants and personal fees from Sanofi; personal fees from Daiichi Sankyo; grants and personal fees from Pfizer; grants and personal fees from Ono; personal fees from Bayer; grants and personal fees from Novartis; personal fees from Behringer; grants and personal fees from Tanabe Mitsubishi; personal fees from Kowa; grants and personal fees from Kyowa Hakko Kirin; personal fees from Dainippon Sumitomo; personal fees from Sawai; personal fees from MSD; grants and personal fees from Abbott; grants and personal fees from Otsuka; grants from Calpis; grants from Nihon Kohden; personal fees from Shionogi; personal fees from AstraZeneca; personal fees from Asahi Kasei Med.; personal fees from Novo Nordisk; personal fees from Fujifilm RI; and personal fees from Japan Medical Data. Dr. Asakura reports grants from Actelion Pharmaceutical Japan; grants from Boehringer Ingelheim Japan, Inc.; personal fees from Otsuka Pharmaceutical Co., Ltd.; personal fees from Sanofi K.K.; personal fees from Bayer Yakuhin, Ltd.; personal fees from MSD K.K.; personal fees from Takeda Pharmaceutical Company Limited; personal fees from Ono Pharmaceutical Co., LTD.; personal fees from Mitsubishi Tanabe Pharma Corporation; personal fees from Daiichi Sankyo; personal fees from Pfizer Japan Inc.; and personal fees from Astellas Amgen Biopharma, outside the submitted work. Dr. Abe reports grants from Teijin, grants from Abbott, grants from Shionogi, grants and personal fees from Daiichi Sankyo, grants and personal fees from Bayer, grants and personal fees from Bristol-Myers Squibb, grants from Ono, grants from Novartis, grants from Pfizer, personal fees from Toa Eiyo, personal fees from Boehringer Ingelheim, personal fees from Dainippon Sumitomo, personal fees from Otsuka, personal fees from Philips, personal fees from GE, personal fees from Siemens, and grants from Japanese government, outside the submitted work. Dr. Ajioka has nothing to disclose. Dr. Aonuma has nothing to disclose. Dr. Anzai has nothing to disclose. Dr. Hayashi has nothing to disclose. Dr. Hiramitsu reports personal fees from null, during the conduct of the study, and personal fees from Tanabe Mitsubishi; personal fees from Daiichi Sankyo; personal fees from Bayer; personal fees from Takeda; personal fees from Asteras; personal fees from MSD; and personal fees from Kowa, from null, outside the submitted work. Dr. Kawai has nothing to disclose. Dr. Kioka has nothing to disclose. Dr. Kimura has nothing to disclose. Dr. Lim has nothing to disclose. Dr. Matsuoka has nothing to disclose. Dr. Motoki has nothing to disclose. Dr. Nagata has nothing to disclose. Dr. Nakamura has nothing to disclose. Dr. Ohte has nothing to disclose. Dr. Ozaki has nothing to disclose. Dr. Sasaoka has nothing to disclose. Dr. Tamaki reports non-financial support from Bristol-Myers Squibb Company, non-financial support from Eli Lilly and Company, non-financial support from Otsuka Pharmaceutical, non-financial support from Boehringer Ingelheim, non-financial support from Toa Eiyo, non-financial support from Nihon Medi-Physics, non-financial support from Medtronic, and non-financial support from Nikkei Business Publications, outside the submitted work. Dr. Hamasaki has nothing to disclose. Dr. Kitakaze reports grants from Japanese government, during the conduct of the study, and grants from Japanese government; grants from Japan Heart Foundation; grants from Japan Cardiovascular Research Foundation; grants and personal fees from Asteras; personal fees from Daiichi Sankyo; grants and personal fees from Pfizer; grants and personal fees from Ono; personal fees from Bayer; grants from Novartis; grants and personal fees from Tanabe Mitsubishi; personal fees from Kowa; personal fees from MSD; grants from Nihon Kohden; personal fees from Shionogi; personal fees from Astrazeneca; grants and personal fees from Astra Zeneca; personal fees from Taisho Toyama; personal fees from Toyama Kagaku; grants and personal fees from Kureha; and personal fees from Toa Eiyo, outside the submitted work.
: Persons from Takeda Pharmaceutical Company Limited will not be involved in conducting this study and analysis, and intentions of Takeda Pharmaceutical Company Limited will not be reflected in the results and interpretations of this study.